FFO
RCUS icon

Fortitude Family Office’s Arcus Biosciences RCUS Stock Holding History

Fortitude Family Office’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39K Buy
+45
New +$1.11K ﹤0.01% 1624
2025
Q3 		– Sell
-60
Closed -$488 – 2108
2025
Q2 		$488 Buy
+60
New +$512 ﹤0.01% 1828

Other funds holding RCUS

New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Fortitude Family Office's RCUS Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 45 shares worth $1.39K. The stake represents ﹤0.01% of the portfolio and ranks #1624 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in RCUS as recently as Q2 2025.

Fortitude Family Office first reported a position in RCUS in Q2 2025 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Fortitude Family Office held 45 shares of Arcus Biosciences worth $1.39K as of Q2 2026.
  • Arcus Biosciences was a new Fortitude Family Office position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1624 holding.
  • Fortitude Family Office first reported a position in Arcus Biosciences in Q2 2025 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.